Provider Workforce Assessment in a Rural Hepatitis C Epidemic

New recommendations for birth cohort screening for hepatitis C virus (HCV) infection and the development of new, highly effective antiviral medications are expected to increase the demand for HCV treatment. In the past, antiviral therapy for HCV was almost exclusively prescribed by specialists in th...

Full description

Saved in:
Bibliographic Details
Published inJournal of primary care & community health Vol. 6; no. 3; pp. 215 - 217
Main Authors Westergaard, Ryan P, Stockman, Lauren J, Hyland, Heather A, Guilfoyle, Sheila M, Fangman, John J, Vergeront, James M
Format Journal Article
LanguageEnglish
Published Thousand Oaks SAGE PUBLICATIONS, INC 01.07.2015
SAGE Publishing
Subjects
Antiviral drugs
Epidemics
Geographic distribution
Health surveillance
Hepatitis
Hepatitis C
Infectious diseases
Meaning
Medical screening
Prescription drugs
Primary care
Public health
Rural areas
Rural communities
Specialists
Surveillance
Underserved populations
Workforce
United States > US
Wisconsin
Online AccessGet full text

Cover

More Information
Summary:New recommendations for birth cohort screening for hepatitis C virus (HCV) infection and the development of new, highly effective antiviral medications are expected to increase the demand for HCV treatment. In the past, antiviral therapy for HCV was almost exclusively prescribed by specialists in the field of gastroenterology and infectious diseases, meaning that people living in rural areas that are underserved by specialists may have poor access to treatment. We investigated the number and geographic distribution of medical providers who actively prescribed direct acting antiviral drugs for hepatitis C in Wisconsin during 2012. Using public health surveillance data and a state-wide prescription drug database, we found that there was 1 treatment provider for every 340 residents known to be living with HCV. However, 51 of 72 Wisconsin counties had no providers who provided HCV treatment in 2012.Scaling up antiviral treatment to address the epidemic of hepatitis C efficiently and equitably will require strategies to increase the number of treatment providers in rural communities. Providing education, training, and support to the primary care workforce serving rural communities should be considered a potentially effective and efficient approach to preventing future HCV-related illness.
ISSN:2150-1319
2150-1327
DOI:10.1177/2150131914560229